Literature DB >> 18462081

Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines.

Caroline M Mitchell1, Jennifer Balkus, Kathy J Agnew, Susan Cohn, Amneris Luque, Richard Lawler, Robert W Coombs, Jane E Hitti.   

Abstract

The relative effect of HIV-1 infection compared with vaginal infections on vaginal cytokine concentrations is not well characterized. We compared vaginal fluid samples from HIV-1-infected women with those from HIV-negative women, to assess the effect of HIV-1 infection on concentrations of vaginal proinflammatory cytokines and the mucosal defense molecule secretory leukocyte protease inhibitor (SLPI). Twenty-seven HIV-1-infected women and 54 HIV-negative controls, matched for bacterial vaginosis (BV) status, had proinflammatory cytokine [interleukin (IL)-1beta, IL-6, IL-8] and SLPI concentrations measured from archived cervicovaginal lavage and vaginal swab samples using an enzyme-linked immunosorbent assay (ELISA). Log-transformed concentrations were compared by BV and HIV status in univariate analysis using Student's t-test, and in multivariate analysis using a linear regression model. In univariate analysis there were no significant differences in cytokine concentrations among HIV-1-infected and HIV-negative women. In a multivariable linear regression model, BV was significantly associated with an increase in IL-1 beta (p = 0.003). HIV infection was associated with an increased concentration of SLPI (p = 0.008), while BV status was significantly associated with a decrease in SLPI concentrations (p = 0.005). Neither HIV nor BV was associated with changes in IL-6 or IL-8. HIV does not have a major impact on vaginal concentrations of proinflammatory cytokines when controlling for the presence of bacterial vaginosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462081     DOI: 10.1089/aid.2007.0268

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  33 in total

1.  Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.

Authors:  Caroline Mitchell; Jane Hitti; Kathleen Paul; Kathy Agnew; Susan E Cohn; Amneris E Luque; Robert Coombs
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

2.  Longitudinal assessment of pigtailed macaque lower genital tract microbiota by pyrosequencing reveals dissimilarity to the genital microbiota of healthy humans.

Authors:  Gregory T Spear; Ellen Kersh; Patricia Guenthner; Sundaram Ajay Vishwanathan; Douglas Gilbert; M Reza Zariffard; Paria Mirmonsef; Alan Landay; Luyang Zheng; Patrick Gillevet
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-03       Impact factor: 2.205

3.  Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding.

Authors:  Heather B Jaspan; Lenine Liebenberg; Willem Hanekom; Wendy Burgers; David Coetzee; Anna-Lise Williamson; Francesca Little; Landon Myer; Robert W Coombs; Don Sodora; Jo-Ann Passmore
Journal:  J Infect Dis       Date:  2011-09-21       Impact factor: 5.226

4.  Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.

Authors:  Kathryn E Royse; Mirjam-Colette Kempf; Gerald McGwin; Craig M Wilson; Jianming Tang; Sadeep Shrestha
Journal:  J Reprod Immunol       Date:  2012-09-28       Impact factor: 4.054

5.  Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples.

Authors:  Scott A Churchman; John A Moss; Marc M Baum
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-03-02       Impact factor: 3.205

Review 6.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

7.  Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time.

Authors:  Marta E Bull; Laura M Heath; Jennifer L McKernan-Mullin; Kelli M Kraft; Luis Acevedo; Jane E Hitti; Susan E Cohn; Kenneth A Tapia; Sarah E Holte; Joan A Dragavon; Robert W Coombs; James I Mullins; Lisa M Frenkel
Journal:  J Infect Dis       Date:  2013-01-11       Impact factor: 5.226

8.  Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.

Authors:  Betsy C Herold; Marla J Keller; Qiuhu Shi; Donald R Hoover; Colleen A Carpenter; Ashley Huber; Urvi M Parikh; Kathy J Agnew; Howard Minkoff; Christine Colie; Marek J Nowicki; Gypsyamber DʼSouza; D Heather Watts; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

9.  Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.

Authors:  Jill S Huppert; Bin Huang; Chen Chen; Hassan Y Dawood; Raina N Fichorova
Journal:  J Infect Dis       Date:  2013-01-25       Impact factor: 5.226

10.  Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations.

Authors:  Marta Bull; Gerald Learn; Indira Genowati; Jennifer McKernan; Jane Hitti; David Lockhart; Kenneth Tapia; Sarah Holte; Joan Dragavon; Robert Coombs; James Mullins; Lisa Frenkel
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.